5,452 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Elefante Mark B

Elefante Mark B bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 5,452 shares of the healthcare conglomerate’s stock, valued at approximately $2,758,000. UnitedHealth Group accounts for about 2.5% of Elefante Mark B’s investment portfolio, making the stock its 19th biggest holding.

Several other large investors also recently modified their holdings of the company. Sugarloaf Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 17.6% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after buying an additional 1,193 shares in the last quarter. Signal Advisors Wealth LLC increased its stake in UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after purchasing an additional 1,051 shares in the last quarter. Waycross Partners LLC boosted its position in shares of UnitedHealth Group by 2.4% during the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after purchasing an additional 658 shares in the last quarter. Czech National Bank raised its stake in UnitedHealth Group by 6.1% during the 4th quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate’s stock worth $100,937,000 after buying an additional 11,426 shares during the period. Finally, Lmcg Investments LLC lifted its holdings in shares of UnitedHealth Group by 11.8% in the fourth quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate’s stock valued at $19,210,000 after purchasing an additional 4,022 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. Erste Group Bank lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, April 30th. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Barclays cut their price target on shares of UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating for the company in a research note on Monday, April 21st. Robert W. Baird dropped their price objective on shares of UnitedHealth Group from $640.00 to $510.00 and set an “outperform” rating for the company in a report on Tuesday, April 29th. Finally, Truist Financial lowered their price target on UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating on the stock in a research report on Monday, April 21st. Four research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $596.86.

UnitedHealth Group Stock Down 1.4 %

UNH stock opened at $385.74 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market cap of $351.11 billion, a PE ratio of 24.89, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a twelve month low of $385.37 and a twelve month high of $630.73. The business has a 50 day moving average of $489.89 and a 200 day moving average of $523.90.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter in the prior year, the business posted $6.91 earnings per share. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.18%. UnitedHealth Group’s dividend payout ratio (DPR) is 35.18%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.